Dapaconazole

N/A

Report date: 2024/11/12 20:00:08
NME

Base Information

Drug NameDapaconazole
Drug Alias Name达帕康唑dapaconazoledapaconazoldapaconazolumBL-123 +[6
ClassificationSmall molecules > Heterocyclic drugs > Antifungals
Mechanisms of ActionLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylase
Therapy Area/IndicationsTinea CrurisTinea Pedis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiolab Sanus Farmaceutica Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsTinea CrurisTinea Pedis

Other Information

ATC CodeN/A
Related LinksN/A